Surmodics Current Ratio 2010-2025 | SRDX
Surmodics current ratio from 2010 to 2025. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations.
| Surmodics Current Ratio Historical Data | |||
|---|---|---|---|
| Date | Current Assets | Current Liabilities | Current Ratio |
| 2025-06-30 | $0.08B | $0.02B | 3.91 |
| 2025-03-31 | $0.07B | $0.01B | 5.14 |
| 2024-12-31 | $0.07B | $0.01B | 5.45 |
| 2024-09-30 | $0.08B | $0.02B | 3.96 |
| 2024-06-30 | $0.08B | $0.02B | 3.98 |
| 2024-03-31 | $0.08B | $0.02B | 4.39 |
| 2023-12-31 | $0.08B | $0.02B | 4.84 |
| 2023-09-30 | $0.09B | $0.02B | 3.62 |
| 2023-06-30 | $0.09B | $0.03B | 2.68 |
| 2023-03-31 | $0.06B | $0.02B | 3.20 |
| 2022-12-31 | $0.06B | $0.02B | 3.73 |
| 2022-09-30 | $0.06B | $0.03B | 1.80 |
| 2022-06-30 | $0.06B | $0.03B | 2.04 |
| 2022-03-31 | $0.07B | $0.03B | 2.28 |
| 2021-12-31 | $0.07B | $0.03B | 2.53 |
| 2021-09-30 | $0.07B | $0.03B | 2.36 |
| 2021-06-30 | $0.09B | $0.02B | 5.33 |
| 2021-03-31 | $0.09B | $0.02B | 5.93 |
| 2020-12-31 | $0.08B | $0.01B | 6.50 |
| 2020-09-30 | $0.09B | $0.02B | 4.58 |
| 2020-06-30 | $0.09B | $0.02B | 5.62 |
| 2020-03-31 | $0.08B | $0.01B | 5.82 |
| 2019-12-31 | $0.07B | $0.01B | 5.18 |
| 2019-09-30 | $0.08B | $0.02B | 4.03 |
| 2019-06-30 | $0.07B | $0.02B | 4.04 |
| 2019-03-31 | $0.07B | $0.02B | 3.52 |
| 2018-12-31 | $0.07B | $0.02B | 3.46 |
| 2018-09-30 | $0.08B | $0.04B | 2.32 |
| 2018-06-30 | $0.08B | $0.03B | 2.50 |
| 2018-03-31 | $0.08B | $0.03B | 2.38 |
| 2017-12-31 | $0.06B | $0.02B | 3.07 |
| 2017-09-30 | $0.06B | $0.01B | 6.21 |
| 2017-06-30 | $0.06B | $0.01B | 7.64 |
| 2017-03-31 | $0.06B | $0.01B | 8.66 |
| 2016-12-31 | $0.06B | $0.01B | 9.55 |
| 2016-09-30 | $0.06B | $0.01B | 5.78 |
| 2016-06-30 | $0.05B | $0.01B | 6.70 |
| 2016-03-31 | $0.05B | $0.01B | 6.23 |
| 2015-12-31 | $0.05B | $0.01B | 9.49 |
| 2015-09-30 | $0.07B | $0.01B | 14.42 |
| 2015-06-30 | $0.07B | $0.00B | 15.35 |
| 2015-03-31 | $0.06B | $0.00B | 16.82 |
| 2014-12-31 | $0.04B | $0.00B | 11.03 |
| 2014-09-30 | $0.06B | $0.00B | 13.59 |
| 2014-06-30 | $0.05B | $0.00B | 12.34 |
| 2014-03-31 | $0.05B | $0.00B | 13.77 |
| 2013-12-31 | $0.03B | $0.00B | 7.38 |
| 2013-09-30 | $0.04B | $0.01B | 5.99 |
| 2013-06-30 | $0.04B | $0.00B | 10.09 |
| 2013-03-31 | $0.05B | $0.00B | 13.20 |
| 2012-12-31 | $0.04B | $0.01B | 5.75 |
| 2012-09-30 | $0.04B | $0.01B | 5.79 |
| 2012-06-30 | $0.09B | $0.01B | 16.60 |
| 2012-03-31 | $0.09B | $0.01B | 14.79 |
| 2011-12-31 | $0.08B | $0.01B | 12.56 |
| 2011-09-30 | $0.06B | $0.01B | 4.94 |
| 2011-06-30 | $0.05B | $0.01B | 6.73 |
| 2011-03-31 | $0.04B | $0.01B | 4.06 |
| 2010-12-31 | $0.04B | $0.01B | 4.45 |
| 2010-09-30 | $0.04B | $0.01B | 4.90 |
| 2010-06-30 | $0.04B | $0.01B | 5.17 |
| 2010-03-31 | $0.04B | $0.01B | 5.47 |
| 2009-12-31 | $0.04B | $0.01B | 5.92 |
| 2009-09-30 | $0.04B | $0.01B | 4.64 |
| 2009-06-30 | $0.04B | $0.01B | 4.37 |
| 2009-03-31 | $0.03B | $0.02B | 2.20 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $0.532B | $0.126B |
| Surmodics is a leading provider of medical device and In Vitro Diagnostics (IVD) technologies to the healthcare industry. It reports through two divisions: Medical Devices & IVD.?The Medical Devices segment comprises surface modification coating technologies to improve access, deliverability, and predictable deployment of medical devices, international cardiology and peripheral balloon design, development and manufacturing, as well as drug delivery coating technologies to provide site-specific drug delivery from the surface of a medical device, with end markets that include coronary, peripheral, neuro-vascular and urology, among others. The IVD segment includes component products and technologies for diagnostic test kits and biomedical research applications, with products that include protein stabilization reagents, substrates, antigens and surface coatings. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $230.767B | 27.06 |
| Boston Scientific (BSX) | United States | $157.318B | 37.52 |
| Stryker (SYK) | United States | $150.713B | 30.68 |
| EssilorLuxottica (ESLOY) | France | $147.808B | 0.00 |
| Medtronic (MDT) | Ireland | $118.836B | 16.76 |
| Lonza Group Ag (LZAGY) | Switzerland | $49.610B | 0.00 |
| Haleon (HLN) | United Kingdom | $44.076B | 25.18 |
| ResMed (RMD) | United States | $43.006B | 30.76 |
| Agilent Technologies (A) | United States | $34.551B | 22.52 |
| GE HealthCare Technologies (GEHC) | United States | $34.343B | 16.14 |
| Terumo (TRUMY) | Japan | $27.701B | 32.82 |
| Koninklijke Philips (PHG) | Netherlands | $27.289B | 18.05 |
| Insulet (PODD) | United States | $23.284B | 78.01 |
| Zimmer Biomet Holdings (ZBH) | United States | $21.337B | 13.58 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $16.420B | 0.00 |
| Baxter (BAX) | United States | $12.604B | 9.74 |
| Sunny Optical Technology (SNPTF) | China | $10.800B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $8.222B | 30.20 |
| Demant (WILYY) | Denmark | $8.121B | 0.00 |
| Lantheus Holdings (LNTH) | United States | $3.958B | 10.70 |
| Envista Holdings (NVST) | United States | $3.609B | 25.26 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| Perrigo (PRGO) | Ireland | $3.369B | 8.42 |
| Prestige Consumer Healthcare (PBH) | United States | $3.283B | 14.57 |
| ICU Medical (ICUI) | United States | $3.164B | 21.54 |
| Haemonetics (HAE) | United States | $2.716B | 12.12 |
| LeMaitre Vascular (LMAT) | United States | $2.271B | 48.70 |
| Acuren (TIC) | United States | $2.108B | 0.00 |
| QuidelOrtho (QDEL) | United States | $1.894B | 11.92 |
| Curaleaf Holdings (CURLF) | Canada | $1.891B | 0.00 |
| AtriCure (ATRC) | United States | $1.872B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.757B | 75.45 |
| Phibro Animal Health (PAHC) | United States | $1.316B | 16.82 |
| AdaptHealth (AHCO) | United States | $1.300B | 18.48 |
| Tilray Brands (TLRY) | Canada | $1.266B | 0.00 |
| BioLife Solutions (BLFS) | United States | $1.241B | 2591.00 |
| Neogen (NEOG) | United States | $1.225B | 19.45 |
| Valneva SE (VALN) | France | $0.990B | 0.00 |
| Kestra Medical Technologies (KMTS) | United States | $0.954B | 0.00 |
| InMode (INMD) | Israel | $0.936B | 8.66 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.624B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.607B | 0.00 |
| SNDL (SNDL) | Canada | $0.591B | 0.00 |
| Verano Holdings (VRNOF) | United States | $0.561B | 0.00 |
| ZimVie (ZIMV) | United States | $0.534B | 20.60 |
| Evolus (EOLS) | United States | $0.497B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.482B | 16.60 |
| CeriBell (CBLL) | United States | $0.442B | 0.00 |
| Owens & Minor (OMI) | United States | $0.390B | 3.46 |
| Sanuwave Health (SNWV) | United States | $0.386B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.325B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.317B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.306B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.305B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.302B | 0.00 |
| Omeros (OMER) | United States | $0.299B | 0.00 |
| High Tide (HITI) | Canada | $0.290B | 0.00 |
| Brainsway (BWAY) | Israel | $0.287B | 58.46 |
| Viemed Healthcare (VMD) | United States | $0.284B | 21.50 |
| Aurora Cannabis (ACB) | Canada | $0.282B | 0.00 |
| Cerus (CERS) | United States | $0.243B | 0.00 |
| Vireo Growth (VREOF) | United States | $0.241B | 0.00 |
| Quanterix (QTRX) | United States | $0.224B | 0.00 |
| Exagen (XGN) | United States | $0.222B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.219B | 0.00 |
| Organigram Global (OGI) | Canada | $0.214B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.195B | 16.30 |
| TriSalus Life Sciences (TLSI) | United States | $0.191B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.160B | 19.65 |
| Biote (BTMD) | United States | $0.159B | 5.28 |
| Jushi Holdings (JUSHF) | United States | $0.133B | 0.00 |
| Jin Medical (ZJYL) | China | $0.113B | 0.00 |
| MacroGenics (MGNX) | United States | $0.107B | 0.00 |
| Fonar (FONR) | United States | $0.095B | 12.19 |
| Quipt Home Medical (QIPT) | United States | $0.093B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.088B | 0.00 |
| Apyx Medical (APYX) | United States | $0.079B | 0.00 |
| Safety Shot (SHOT) | United States | $0.070B | 0.00 |
| Agape ATP (ATPC) | $0.066B | 0.00 | |
| Cytosorbents (CTSO) | United States | $0.057B | 0.00 |
| ImmuCell (ICCC) | United States | $0.055B | 32.07 |
| Veru (VERU) | United States | $0.053B | 0.00 |
| Zynex (ZYXI) | United States | $0.050B | 0.00 |
| Nephros (NEPH) | United States | $0.044B | 34.83 |
| Modular Medical (MODD) | United States | $0.040B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.039B | 0.00 |
| United-Guardian (UG) | United States | $0.038B | 14.95 |
| Trinity Biotech (TRIB) | Ireland | $0.028B | 0.00 |
| Senestech (SNES) | United States | $0.023B | 0.00 |
| INLIF (INLF) | $0.018B | 0.00 | |
| Allurion Technologies (ALUR) | United States | $0.017B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.016B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.013B | 0.00 |
| Flora Growth (FLGC) | United States | $0.012B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.012B | 0.00 |
| Sharps Technology (STSS) | United States | $0.008B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.007B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.005B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| InterCure (INCR) | Israel | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |